Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1981 1
1982 1
1983 1
1984 3
1986 7
1987 5
1988 9
1989 6
1990 7
1991 16
1992 22
1993 18
1994 16
1995 28
1996 30
1997 22
1998 40
1999 37
2000 47
2001 61
2002 89
2003 119
2004 110
2005 165
2006 187
2007 230
2008 280
2009 284
2010 353
2011 420
2012 536
2013 630
2014 814
2015 903
2016 1064
2017 1212
2018 1418
2019 1658
2020 1926
2021 2186
2022 2686
2023 2580
2024 2937
2025 3089
2026 59

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,646 results

Results by year

Filters applied: . Clear all
Page 1
LPS-Binding Hydrogel for TLR4-Mediated Microbiota-Immune Modulation.
Chen J, Wu C, Yang R, Chen Z, Yang X, Xu Y, Cheng X, Sui H, Zhang S, Zhu X, Wu M, Huang Y, Chen X, Liu H, Yang J, Tan X, Chen F, Cheng C, Shao D, Han X, Shi B, Yang C, Leong KW, Huang H. Chen J, et al. Among authors: han x. Adv Mater. 2025 Nov 19:e14484. doi: 10.1002/adma.202514484. Online ahead of print. Adv Mater. 2025. PMID: 41255157
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study.
Zhong J, Wu L, Song Z, Xing N, Cui J, Li X, Fei K, Tang D, Dang Q, Chen L, Liu T, Liu C, Li Y, Zhang S, Han X, Xiao J, Guo F, Yan M, Xu H, Yuan C, Zhong J, Liu R, Qu X, Wu S, Jiang S, Yang Y, Zhang P, Guo H, Wang C, Xie Q, Lin Z, Wang S, Wang J. Zhong J, et al. Among authors: han x. Cancer Cell. 2025 Dec 8;43(12):2268-2281.e3. doi: 10.1016/j.ccell.2025.09.012. Epub 2025 Oct 23. Cancer Cell. 2025. PMID: 41135519 Clinical Trial.
Measurement of the Z-Boson Mass.
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adefisoye AA, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreola P, Andreotti M, Anelli A, Ao D, Archilli F, Areg Z, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Ataíde Da Silva R, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Baladron Rodriguez P, Balagura V, Balboni A, Baldini W, Balzani L, Bao H, Baptista de Souza Leite J, Barbero Pretel C, Barbetti M, Barbosa IR, Barlow RJ, Barnyakov M, Barsuk S, Barter W, Bartz J, Bashir S, Batsukh B, Battista PB, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Behling NA, Belin S, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bezshyyko O, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blake T, Blanc F, Blank JE, Blusk S, Bocharnikov V, Boelhauve JA, Boente Garcia O, B… See abstract for full author list ➔ Aaij R, et al. Among authors: han x. Phys Rev Lett. 2025 Oct 17;135(16):161802. doi: 10.1103/ydn7-qx1d. Phys Rev Lett. 2025. PMID: 41172198
Dynamic shifts in plant-microbe relationships.
Osayande IS, Han X, Tsuda K. Osayande IS, et al. Among authors: han x. Plant Biotechnol (Tokyo). 2025 Sep 25;42(3):271-277. doi: 10.5511/plantbiotechnology.25.0428a. Plant Biotechnol (Tokyo). 2025. PMID: 41181069 Free PMC article.
177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial.
Xu J, Chen J, Song S, Song L, Wang R, Hao J, Du X, Cao D, Gao Y, Lan X, Yang A, Miao W, Xu H, Chen Y, Li L, Shi H, Yuan X, Ye F, Wang J, Xu N, Han X, Li X, Huang R, Zhang T, Li E, Wang R, Zhou Y, Chen H, Zhu X, Zhao J, Su X, Cui Y, Ren P, Wang P. Xu J, et al. Among authors: han x. Ann Oncol. 2025 Dec;36(12):1458-1467. doi: 10.1016/j.annonc.2025.08.3758. Epub 2025 Oct 18. Ann Oncol. 2025. PMID: 41111031 Clinical Trial.
23,646 results
You have reached the last available page of results. Please see the User Guide for more information.